Contact
searchSearch
HMP Global

Formulary Frontlines®

Formulary Frontlines®
Comparative Review of Anticoagulant Coverage Across 3 Major Health Plans
11/14/2024
When thinking of anticoagulants as a drug class, their treatment and usage across therapeutic areas is vast and growing. Anticoagulants can treat patients across these therapeutic areas, from blood clotting disorders to thromboembolic...
When thinking of anticoagulants as a drug class, their treatment and usage across therapeutic areas is vast and growing. Anticoagulants can treat patients across these therapeutic areas, from blood clotting disorders to thromboembolic...
When thinking of anticoagulants...
11/14/2024
First Report Managed Care
IPF letters
Formulary Frontlines®
New Therapies in Development for Idiopathic Pulmonary Fibrosis (IPF) Address Existing Challenges With Diagnosis and Management
05/13/2024

Reviewed by Elizabeth Volkmann, MD, MS

Reviewed by Elizabeth Volkmann, MD, M...
IPF is a chronic, progressive interstitial lung disease that presents a significant burden to ~3 million patients worldwide. Despite ongoing challenges with IPF diagnosis and management, new therapies in development are showing promise.
IPF is a chronic, progressive interstitial lung disease that presents a significant burden to ~3 million patients worldwide. Despite ongoing challenges with IPF diagnosis and management, new therapies in development are showing promise.
IPF is a chronic, progressive...
05/13/2024
First Report Managed Care
Formulary Frontlines®
Challenges, Treatment Options, and Costs Linked With Upper Tract Urothelial Carcinoma
06/20/2023
Bladder cancer was the sixth most common cancer type in the United States in 2020, behind breast, lung, prostate, colon, and skin cancers.
Bladder cancer was the sixth most common cancer type in the United States in 2020, behind breast, lung, prostate, colon, and skin cancers.
Bladder cancer was the sixth...
06/20/2023
First Report Managed Care
Formulary Frontlines®
Lurbinectedin Proves Effective as Second-line Therapy Option for Patients With Metastatic SCLC
04/07/2021
"Seeing first-hand the aggressive nature of SCLC and knowing that the large majority of those diagnosed will experience relapse, I am excited to see an effective new treatment demonstrating durable responses," said William Jeffrey Petty, MD,...
"Seeing first-hand the aggressive nature of SCLC and knowing that the large majority of those diagnosed will experience relapse, I am excited to see an effective new treatment demonstrating durable responses," said William Jeffrey Petty, MD,...
"Seeing first-hand the...
04/07/2021
First Report Managed Care
Formulary Frontlines®
New Options Available for Treatment-Resistant Depression
11/20/2020
Over the past 30 years, few new pharmacologic therapies have been developed for mood disorders, including depression. However, for patients who do not respond to conventional pharmacologic treatments for MDD, new answers for...
Over the past 30 years, few new pharmacologic therapies have been developed for mood disorders, including depression. However, for patients who do not respond to conventional pharmacologic treatments for MDD, new answers for...
Over the past 30 years, few new...
11/20/2020
First Report Managed Care
Formulary Frontlines®
Reducing Disease Progression, Burden for Patients With Multiple Myeloma
10/15/2020
Although it is rarer than most, multiple myeloma is the second most common blood cancer after non-Hodgkin lymphoma—effecting more than 130,000 adults in the United States.
Although it is rarer than most, multiple myeloma is the second most common blood cancer after non-Hodgkin lymphoma—effecting more than 130,000 adults in the United States.
Although it is rarer than most,...
10/15/2020
First Report Managed Care
Formulary Frontlines®
Achieving Effective Motor Control for Patients With Parkinson Disease
09/25/2020
There is no definitive cure for PD but the main objective is reducing symptoms and achieving effective motor control through medication and surgical therapy. The cornerstone of symptomatic treatment for PD is dopamine replacement therapy.
There is no definitive cure for PD but the main objective is reducing symptoms and achieving effective motor control through medication and surgical therapy. The cornerstone of symptomatic treatment for PD is dopamine replacement therapy.
There is no definitive cure for...
09/25/2020
First Report Managed Care
Formulary Frontlines®
Migraine and Payer Management Challenges
08/31/2020
Headache is extremely common in the general population, but despite its high prevalence and impairment, migraine is often not recognized or effectively treated. Because new classes of drugs and nondrug treatments continue to surface, more...
Headache is extremely common in the general population, but despite its high prevalence and impairment, migraine is often not recognized or effectively treated. Because new classes of drugs and nondrug treatments continue to surface, more...
Headache is extremely common in...
08/31/2020
First Report Managed Care
Formulary Frontlines®
Breakthroughs in Alzheimer Treatment Needed
06/22/2020
Alzheimer disease has tremendous social and economic impact for which there is no known cure, however, strides in diagnosis and epidemiology could one day lead to breakthroughs in treatment.  As one of the most common types of dementia,...
Alzheimer disease has tremendous social and economic impact for which there is no known cure, however, strides in diagnosis and epidemiology could one day lead to breakthroughs in treatment.  As one of the most common types of dementia,...
Alzheimer disease has tremendous...
06/22/2020
First Report Managed Care
Formulary Frontlines®
Using Biologics to Manage Rheumatoid Arthritis
03/31/2020
RA has a significant negative impact on the ability to perform daily activities and on health-related quality of life, conferring a substantial health care and economic burden. Costs attributable to RA are expected to further increase as the...
RA has a significant negative impact on the ability to perform daily activities and on health-related quality of life, conferring a substantial health care and economic burden. Costs attributable to RA are expected to further increase as the...
RA has a significant negative...
03/31/2020
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

News
Special Medicaid Funds Help Most States, but Prompt Oversight Concerns
04/10/2023
A proposed state funding initiative in Georgia could significantly reduce financial losses suffered by rural hospitals, but patient advocates argue adoption of Medicaid expansion is more urgent.
A proposed state funding initiative in Georgia could significantly reduce financial losses suffered by rural hospitals, but patient advocates argue adoption of Medicaid expansion is more urgent.
A proposed state funding...
04/10/2023
First Report Managed Care
News
Patients With Thin-Liquid Dysphagia Benefit From Free Water Protocol at LTACH
04/25/2023
A free water protocol implemented at a long-term acute care hospital improved patients' hydration and quality of life without resulting in aspiration pneumonia, findings show.
A free water protocol implemented at a long-term acute care hospital improved patients' hydration and quality of life without resulting in aspiration pneumonia, findings show.
A free water protocol...
04/25/2023
First Report Managed Care
News
DMT Switching Associated With Lower Adherence, Persistence Among Patients With MS
05/24/2023
The findings indicate there "may be an opportunity for added care coordination or resources to optimize therapy transitions" for patients with multiple sclerosis, according to the researchers.
The findings indicate there "may be an opportunity for added care coordination or resources to optimize therapy transitions" for patients with multiple sclerosis, according to the researchers.
The findings indicate there "may...
05/24/2023
First Report Managed Care
Feature Story
Payers Bet Big on Home Health Care
06/20/2023
Large health insurers are making multibillion-dollar deals to acquire home health care providers. Here’s why.
Large health insurers are making multibillion-dollar deals to acquire home health care providers. Here’s why.
Large health insurers are making...
06/20/2023
First Report Managed Care
News
Disparities Between Guideline Recommendations, Implementation of Pharmacokinetic Dosing for Bleeding Disorders
07/17/2023
Authors of a recent scoping review explored trends in the efficacy and feasibility of implementing pharmacokinetic-guided dosing in clinical practice for patients with bleeding disorders.
Authors of a recent scoping review explored trends in the efficacy and feasibility of implementing pharmacokinetic-guided dosing in clinical practice for patients with bleeding disorders.
Authors of a recent scoping...
07/17/2023
First Report Managed Care

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use